An interventional study of Multimodal prehabilitation intervention and Control (Standard treatment) in Ischaemic Heart Disease, Prehabilitation and Coronary Artery Bypass, sponsored by Rigshospitalet, Denmark. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-29.
Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Coronary Artery Disease by Rigshospitalet, Denmark — 5 open to participants now, 6 under way, none of them phase 3. Coronary Artery Disease · Rigshospitalet, Denmark.
Among the 18 studies in Coronary Artery Disease by Rigshospitalet, Denmark, this one is the 14th largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2025, is one of 14 with no phase, and was the 18th registered.
4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.
Browse Coronary Artery Disease studies →5 of the 18 studies in Coronary Artery Disease by Rigshospitalet, Denmark are open now, in 3 countries. Recruiting first, the newest first:
Rigshospitalet, Denmark · Sites in Denmark
Rigshospitalet, Denmark · Sites in Denmark
Ages 18+
Rigshospitalet, Denmark · Sites in Denmark
Ages 18+
Rigshospitalet, Denmark · Sites in Belgium, Denmark, Netherlands
Ages 18–80
By country, each count listing its studies:
Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 123 across 3,011 interventional studies indexed under Coronary Artery Disease.
Median enrollment 331 across the 15 interventional studies, 105 across the 2 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Rigshospitalet, Denmark is the lead sponsor of 1,004 studies on the registry; 173 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Coronary Artery Disease by Rigshospitalet, Denmark, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Patients with ischemic heart disease (IHD) awaiting coronary artery bypass graft (CABG) surgery often face challenges like advanced age, frailty, comorbidities, and physical inactivity. These factors, combined with the physiological and psychological stress of surgery, can hinder postoperative recovery. Traditionally, strategies to improve surgical outcomes focus on the intra- and postoperative periods. However, the pre-surgery waiting period offers a "window of opportunity" for prehabilitation, which aims to enhance patients' functional capacity through exercise, nutrition, and psychological support.
The CABGpreHAB feasibility study evaluates the feasibility of a home-based multimodal prehabilitation intervention for patients awaiting elective CABG surgery. This randomized pilot study compares the intervention plus usual care to usual care alone, assessing feasibility outcomes like recruitment, retention, attrition, fidelity, and adherence. The study aims to optimize a subsequent full-scale randomized controlled trial (RCT) and improve patient outcomes by leveraging the pre-surgery period for prehabilitation.
Advanced age, frailty, comorbidity, and physical inactivity are often present in patients with ischemic heart disease (IHD) awaiting coronary artery bypass graft surgery (CABG). These characteristics, as well as the physiological impact of having surgery, are significant homeostatic disturbances where patients postoperatively suffer from physical symptoms and a lack of return to independence. Cardiac surgery invariably induces varying degrees of physiological stress, impacting multiple organ systems, and imposes a psychological burden. As age increases, patient complexity and comorbid burden grow more common in patients undergoing cardiac surgery; innovative strategies are required to alleviate the risk of adverse outcomes. Strategies to improve outcomes from surgery and accelerate return to baseline levels have traditionally focused on the intra- and postoperative period, nevertheless, the waiting period before surgery might offer an opportunity for improving the safety and outcome of the surgical intervention and improving patients' motivation in postoperative rehabilitation and recovery time. Prehabilitation is a newly introduced term that reflects a proactive process of enhancing an individual's functional capacity between diagnosis and scheduled surgery, intending to improve the patient's capacity to withstand the upcoming physiologic stress of surgery and thus avoid complications. This period of awaiting surgery is proposed as a "window of opportunity" to address poor nutritional status, low physical fitness, and high emotional distress. The role of multimodal prehabilitation combining exercise training, nutritional optimization, and psychological support, in patients with IHD awaiting CABG surgery, is sparse and unknown in a Danish setting
Objective:
This CABG preHAB feasibility study is conducted to evaluate the feasibility of delivering a homebased multimodal prehabilitation intervention for patients awaiting elective CABG surgery with the purpose to optimize a subsequent full-scale RCT.
Design:
The CABGpreHAB feasibility study is designed as a randomized pilot study, aiming to assess the feasibility of a multimodal prehabilitation intervention plus usual care versus usual care alone in patients awaiting elective CABG surgery. It is an investigator-initiated study designed as an open-label, single-center randomized controlled feasibility study (allocation ratio 1:1) with blinded outcome assessment, designed to assess the method proposed for use in a larger RCT.
Study population:
Patients aged more than 18 years awaiting elective CABG-surgery
Primary outcomes:
Feasibility outcomes include:
Recruitment and retention rates. The recruitment rate will be determined by the number of individuals participating in the study out of those who are eligible/admissible but refuse to participate. First, the investigators will evaluate the number of patients that can be included in the study during the inclusion period. A proportion of 60% or more of patients awaiting elective CABG surgery who are eligible for the study is acceptable. Retention will be assessed by the percentage of participants who remain in the study from the beginning to the end of the study (30 days post-surgery).
Attrition rates. Attrition is defined by the number of individuals who consent to participate in the study but drop out before the end of the intervention period, regardless of group allocation.
Fidelity. Fidelity of delivery of the webcam-based exercise training intervention will be assessed qualitatively by 8-10 semi-structured interviews, the day before surgery, by a research nurse.
Adherence to the interventions will be measured by using the number of telephone counselling and tele-exercise sessions delivered out of the theoretical number that could have been delivered based on the surgical wait time of each participant. Adherence to the home-based tele-exercise training sessions and telephone counselling by assessing the number of sessions applied in the intervention group. This will be collected by the patient's recorded physical activity logbook, by weekly phone calls, and by accelerometer data. Adherence with the prehabilitation program will be assessed against the target of individuals achieving > 70% of the prescribed exercise program (self-reported) + during the study follow-up with phone calls. Inclusion in the CABGpreHAB study must be attractive to at least 30% of eligible patients who meet the inclusion criteria. The interventions must be widely accepted, with at least 70% of included participants completing 70% or more of the planned sessions in the intervention group. Safety of the intervention will be determined based on the number and nature of adverse events (AE).
Secondary outcomes:
Secondary outcomes will assess the patients' responses to the multimodal prehabilitation programme, and data will be collected on explorative outcomes, measured at baseline, the day before surgery and 30 days PO.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients randomized to the multimodal prehabilitation programme will, besides usual care, receive home-based preoperative interventions that consist of: Web-based exercise intervention supervised by skilled physiotherapists and delivered via a tablet. Each session lasts 60 minutes, three times per week for the prehabilitation period. Patients will be instructed to perform daily exercise tasks such as brisk walking and sit-to-stand exercises. Phone call and consultation delivered by a specialised nurse once a week. This consultation will deliver psychosocial support, equipping patients with coping strategies to mitigate stress, anxiety, and depression. Furthermore, nutritional advice will take place at these consultations, as well as advice on smoking cessation and alcohol cessation.
Other: Multimodal prehabilitation intervention
Participants assigned to the control group will receive usual care.
Other: Control (Standard treatment)
Multimodal prehabilitation interventions (CABGpreHAB): * Home-based exercise intervention delivered by a skilled physiotherapist via a web-based application. * Nutritional intervention * Psycho-educative intervention * Smoking cessation * Alcohol cessation
This includes standard information about CABG surgery, pre- and postoperative care, and postoperative physical activity advice. Patients are either admitted days before or on the day before surgery. They receive written materials and links to animated videos about preparing for surgery. This preparation includes counseling with a multidisciplinary team, including a department nurse, a physiotherapist, a cardiac anesthesiologist, and a surgeon.
Feasibility outcome: recruitement rate
Determined by the number of individuals participating in the study out of those eligible during the inclusion period.
Time frame: Through study completition, an average of 1 year
Feasibility outcome: Attrition rates
Defined by the numbers of individuals who give consent to participate, but drop out before study ends.
Time frame: Up to 30 days post surgery index
Feasibility outcome: Fidelity
Fidelity of delivery on the web-based exercise training intervention will be assessed qualitatively by semi-structured interviews
Time frame: preoperative
Feasibility outcome: Adherence rates
Adherence will be assessed by measuring the number of telephone counseling and exercise sessions delivered during the intervention period.
Time frame: Preoperative
Feasibility outcome: Safety
Safety of the intervention will be determined based on the number and nature of adverse events.
Time frame: From enrolement to the day before surgery
Exercise capacity
6MWT measures total walking distance in meters completed in six minutes
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
Muscle strength
30 seconds sit-to-stand measured by numbers of sit-to-stands in 30 seconds
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
Muscle strength handgrip
Measured in kilograms using a hand-held dynamometer
Time frame: At baseline and preoperative
Bodycomposition
Using a Bioelectrical Impedance Analyzer (BIA), body composition estimation: fat mass in kilograms, Fat mass as a percentage of weight, Fat-free mass in kilograms, Fat-free mass as a percentage of weight
Time frame: At baseline and preoperative
Nutritional status
Weight and height combined to report BMI in kg/m\^2, and Screened by the NRS2002 score
Time frame: At baseline and preoperative
Daily physical activity
SENS motion accelerometer measures minutes of physical activity as steps, Cyckling running Standing Laying
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
HRQOL
The Questionnaire SF-12 measures overall health status
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
Heart-specific QoL
The Questionnaire HeartQoL measures health-related quality of life in patients with ischemic heart disease
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
Anxiety
The State-Trait Anxiety Inventory Questionnaire measures two disitnc types of anxiety
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
Depression
The PHQ-4 Questionnaire measures depression and anxiety
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
Sense of coherence
The SOC-13 Questionnaire assesses an individual´s ability to manage stress and maintain health
Time frame: At baseline
Self-efficacy/self-management
The PAM13 Questionnaire assesses an individual's knowledge, skill, and confidence for self-management
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
Tobacco uses status
Self-Reported Questionnaire
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
Alcohol uses status
Self-Reported Questionnaire
Time frame: Three times: at baseline, preoperative and 30 days post surgery index
Complications postoperatively
Rates of pneumonia, atelectasis, hemorrhage, cardiac arrhythmias, and delirium will be measured postoperatively
Time frame: From date of surgery and up to 30 days postopetively.
ICU-LOS
ICU-LOS will be calculated in hours
Time frame: From date and time of surgery until the date and time of discharge to the ward.
LOS
LOS will be calculated in days
Time frame: From date of surgery until date of discharge from the ward
DAOH30
DAOH30 will be calculated in days
Time frame: From date of surgery and up to 30 days postopetively.
Participating in Cardiac rehabilitation
Participation will be calculated in percentage
Time frame: At 30 days postoperatively
Bloodtest
HGB measured in mmol/l Albumin measured in g/l CRP measured in mg/l Creatinine measured in micromol/l
Time frame: At baseline and postoperatively day 4
Plan to share: No
Started Jun 2025 (actual). Primary completion is estimated for Jun 2026, 11 months after the start.
Of 756 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's planned 11 months is below that.
Counting every sponsor, half of 933 studies reached it within 30 months; a quarter within 15 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.